Stem cells: HSCT for systemic sclerosis - Swallows and summers

Nature Reviews Rheumatology

Volumn 7, Issue 11, 2011, Pages 624-626

  Tyndall, Alan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MEPREDNISONE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CYTOKINE RELEASE SYNDROME; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SHORT SURVEY; STEM CELL MOBILIZATION; SYSTEMIC SCLEROSIS; TREATMENT DURATION;

CYCLOPHOSPHAMIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 80455154979     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.136     Document Type: Short Survey

References (10)

1. Burt, R. K. et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 378, 498-506 (2011).
2. Farge, D. et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 95, 284-292 (2010).
3. van Laar, J. M., Farge, D. & Tyndall, A. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis. Ann. Rheum. Dis. 64, 1515 (2005).
4. Bryan, C., Knight, C., Black, C. M. & Silman, A. J. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum. 42, 2660-2665 (1999).
5. Griffiths, B. et al. Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function. J. Rheumatol. 29, 2371-2378 (2002).
6. Gratwohl, A. et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 35, 869-879 (2005).
7. Bacigalupo, A. et al. Defining the intensity of conditioning regimens: working definitions. Biol. Blood Marrow Transplant. 15, 1628-1633 (2009).
8. Czirjak, L. et al. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann. Rheum. Dis. 66, 966-969 (2007).
9. van den Hoogen, F. H. et al. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. Br. J. Rheumatol. 35, 364-372 (1996).
10. Berry, D. A. et al. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials. J. Clin. Oncol. 20, 3224-3231 (2011).